Cargando…
Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis
The aim of the present study was to investigate the effects of three blood purification methods on fibroblast growth factor-23 (FGF-23) clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis (MHD). In addition, the correlation between serum FGF-23 and phosphorus (Pi) levels...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964936/ https://www.ncbi.nlm.nih.gov/pubmed/24669256 http://dx.doi.org/10.3892/etm.2014.1543 |
_version_ | 1782479261862461440 |
---|---|
author | MIAO, LI-YING ZHU, BIN HE, XIAO-ZHOU LIU, JIN-FENG JIN, LI-NA LI, XIU-RONG XUE, LI-NA HUANG, TIAN SHEN, JIAN-QIN XING, CHANG-YING |
author_facet | MIAO, LI-YING ZHU, BIN HE, XIAO-ZHOU LIU, JIN-FENG JIN, LI-NA LI, XIU-RONG XUE, LI-NA HUANG, TIAN SHEN, JIAN-QIN XING, CHANG-YING |
author_sort | MIAO, LI-YING |
collection | PubMed |
description | The aim of the present study was to investigate the effects of three blood purification methods on fibroblast growth factor-23 (FGF-23) clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis (MHD). In addition, the correlation between serum FGF-23 and phosphorus (Pi) levels and the clinical implications were identified. Sixty-five MHD patients with hyperphosphatemia were randomly divided into three groups: Hemodialysis, HD (n=23); hemodiafiltration, HDF (n=21); and hemodialysis+hemoperfusion, HD+HP (n=21) groups. Serum Pi, FGF-23, blood urea nitrogen, serum creatinine and associated bio-marker levels were measured prior to and following treatment. The expression level of serum FGF-23 was observed to be positively correlated with Pi (r=0.45, P<0.01). The three blood purification methods that were adopted for the present study exhibited significant and effective clearance of serum Pi (P<0.05). The post-treatment serum FGF-23 levels were significantly decreased in the HDF and HD+HP groups (P<0.05). Therefore, HDF may be an effective method for clearing serum FGF-23 in MHD patients exhibiting hyperphosphatemia. |
format | Online Article Text |
id | pubmed-3964936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-39649362014-03-25 Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis MIAO, LI-YING ZHU, BIN HE, XIAO-ZHOU LIU, JIN-FENG JIN, LI-NA LI, XIU-RONG XUE, LI-NA HUANG, TIAN SHEN, JIAN-QIN XING, CHANG-YING Exp Ther Med Articles The aim of the present study was to investigate the effects of three blood purification methods on fibroblast growth factor-23 (FGF-23) clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis (MHD). In addition, the correlation between serum FGF-23 and phosphorus (Pi) levels and the clinical implications were identified. Sixty-five MHD patients with hyperphosphatemia were randomly divided into three groups: Hemodialysis, HD (n=23); hemodiafiltration, HDF (n=21); and hemodialysis+hemoperfusion, HD+HP (n=21) groups. Serum Pi, FGF-23, blood urea nitrogen, serum creatinine and associated bio-marker levels were measured prior to and following treatment. The expression level of serum FGF-23 was observed to be positively correlated with Pi (r=0.45, P<0.01). The three blood purification methods that were adopted for the present study exhibited significant and effective clearance of serum Pi (P<0.05). The post-treatment serum FGF-23 levels were significantly decreased in the HDF and HD+HP groups (P<0.05). Therefore, HDF may be an effective method for clearing serum FGF-23 in MHD patients exhibiting hyperphosphatemia. D.A. Spandidos 2014-04 2014-02-13 /pmc/articles/PMC3964936/ /pubmed/24669256 http://dx.doi.org/10.3892/etm.2014.1543 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles MIAO, LI-YING ZHU, BIN HE, XIAO-ZHOU LIU, JIN-FENG JIN, LI-NA LI, XIU-RONG XUE, LI-NA HUANG, TIAN SHEN, JIAN-QIN XING, CHANG-YING Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title | Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title_full | Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title_fullStr | Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title_full_unstemmed | Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title_short | Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
title_sort | effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964936/ https://www.ncbi.nlm.nih.gov/pubmed/24669256 http://dx.doi.org/10.3892/etm.2014.1543 |
work_keys_str_mv | AT miaoliying effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT zhubin effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT hexiaozhou effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT liujinfeng effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT jinlina effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT lixiurong effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT xuelina effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT huangtian effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT shenjianqin effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis AT xingchangying effectsofthreebloodpurificationmethodsonserumfibroblastgrowthfactor23clearanceinpatientswithhyperphosphatemiaundergoingmaintenancehemodialysis |